Shire chief says DoJ's right to target pharma execs; Sanofi wins OK for talking auto-injector;

 @FiercePharma: Merck KGaA's Rebif (for MS) and Erbitux (cancer) helped push Q2 sales past expectations. Weak euro helped, too. More | Follow @FiercePharma

> Shire CEO Angus Russell agrees with pharma critics who say off-label marketing won't stop until executives themselves go to jail--but his company is under investigation for its promotional practices. Report

> Sanofi ($SNY) won the FDA nod for its talking auto-injector device, Auvi-Q, to be used for epinephrine injections in patients at risk of severe allergic reaction. Report

> Strong growth from Merck KGaA's multiple sclerosis drug Rebif and cancer treatment Erbitux helped push the German drugmakers second-quarter sales past expectations as 376 million euros' worth of restructuring charges weighed on net profits. Report

> Boehringer Ingelheim boosted first-half sales by 6.8% to 7.1 billion euros, fueled by its respiratory drugs Spiriva and Combivent, along with anticoagulant Pradaxa and newly launched diabetes med Trajenta. Report

> European drug distributor Celesio posted a net loss larger than analysts had expected, thanks to write downs on businesses it is shedding in a restructuring. Report

> FDA approved a cadre of influenza vaccines for the 2012-13 flu season, including shots from CSL, GlaxoSmithKline ($GSK), Novartis ($NVS) and Sanofi Pasteur. Report

Medical Device News

 @FierceMedDev: Roche Holdings' heart attack test helped reduce emergency room diagnoses in a new stud--via Bloomberg. Report | Follow @FierceMedDev

 @MarkHFierce: Think an epipen, but shaped like a credit card that offers voice and written instructions. Sanofi made; FDA approved. More | Follow @MarkHFierce

 @DamianFierce: More M&A for Teleflex, this time spending $276M on Singapore's LMA. News | Follow @DamianFierce

> Jarvik moves toward FDA nod for cardiac assist device. Article

> Sanofi's new epinephrine device guides users with voice and written instructions. Item

> Teleflex ponying up $276M for laryngeal mask firm. More

Biotech News

 @FierceBiotech: On eve of Forest proxy showdown, Icahn takes aim at management for undisclosed FDA warning letters. Article | Follow @FierceBiotech

 @JohnCFierce: Booming Shire closes in on new campus site for U.S. HQ. More | Follow @JohnCFierce

 @RyanMFierce: Quintiles, the big CRO, gets bigger via buyout of DNA sequencing and analysis shop Expression Analysis. News | Follow @RyanMFierce

> Genentech whistleblower suit claims execs dangerously rushed Pi3K study. Report

> Unconventional Kineta adds to its bankroll for autoimmune program. Story

Biotech Research News

> Gene offers tantalizing leukemia target. Story

> University of Cambridge debuts latest stem cell research institute. More

> Nanomaterial propels self-repair for damaged hearts. Article

Pharma Manufacturing News

> Internet drug dealer gets 10 years but feds want his Chinese boss. Story

> FTC says GPhA drug shortage plan avoids antitrust issues. More

> FDA asks Merck to make up for Sanofi cancer drug shortage. News

> Thieves target pharmacies, not trucks, in Mexico. Item

> More drugs for U.S. to come from Ranbaxy's Mohali, India, plant. Article

And Finally ... Can an old tuberculosis vaccine stop Type 1 diabetes? A study suggests it's possible. Report